HOMA-IR Primary Evidence Sources:
1. NHANES Data (US National Health Survey, 2007-2021)
- Found 40-44% of US adults aged 18-44 are insulin resistant using HOMA-IR measurements
- Most commonly cited source for the “40%” prevalence figure
- Prevalence has remained consistently high across multiple survey periods
- Analyzed 86 studies from 2001-2024 across multiple countries
- Found overall global IR prevalence of 26.53%, but this varied widely by geographic region and cutoff used
The Critical Cutoff Problem:
Why “40-50% (higher with proper cutoffs)”? Most studies use HOMA-IR cutoffs of 2.5-3.0, which were derived from populations that were already metabolically unhealthy. This creates circular logic—defining “normal” based on sick populations. Different Thresholds Yield Different Results:- Using HOMA-IR ≥2.5 (most common): Captures ~40-45%
- Using HOMA-IR ≥2.0 (conservative): Likely captures 60-65%
- Using HOMA-IR ≥1.9 (Qatar study optimal cutoff): Likely captures 70-75%+
- Using truly healthy populations as reference: Possibly 80-90% in Western societies
Why We Use “40-50% (higher with proper cutoffs)”:
The 40-50% range is:- Well-documented in peer-reviewed NHANES studies
- Conservative and defensible
- Based on widely accepted (though lenient) cutoff of ≥2.5
- The 2.5 threshold is probably too lenient
- Using more stringent cutoffs (1.9-2.0) reveals higher true prevalence
- Actual prevalence in Western populations is likely 60%+ and possibly much higher